Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

AeRang Kim

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Pediatric Blood & Cancer|April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology GroupMeredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 13, 2018
Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU systemAvinash Eranki, Navid Farr, Ari Partanen, et al.
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor TherapyAvinash Eranki, Priya Srinivasan, Mario Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Pediatric Blood & Cancer|April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology GroupMeredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 13, 2018
Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU systemAvinash Eranki, Navid Farr, Ari Partanen, et al.
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor TherapyAvinash Eranki, Priya Srinivasan, Mario Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Pageof 7